SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-03
👔
Contineum Therapeutics, Inc.
@CTNM_InsiderForm 4 Filing: Stengone Carmine N. Sells $42,554 of $CTNM
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Contineum Therapeutics, Inc.
Ticker: $CTNM
Transaction Value
$42,554
Price/Share: $8.51
transaction date
2026-08-03
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Stengone Carmine N., holds the title of CEO and President at Contineum Therapeutics, Inc..
On 2026-08-03, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $8.51 per share, resulting in a total market-relevant value of $42,554.
Executive Summary Summary
Stengone Carmine N. (CEO and President) sold $43K of $CTNM
Post-Transaction Position: 17,217 shares
SEC Accession No: 0001628280-26-052031 (CIK: 1861519)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.